Discover Qazaqstan via News and Inspiring Stories

QazMonitor Logo
Facebook Qazmonitor iconInstagram Qazmonitor iconTiktok Qazmonitor iconTwitter Qazmonitor iconTelegram Qazmonitor iconYoutube Qazmonitor icon
  1. Main Page
  2. Business
  3. Kazakhstan and AstraZeneca Signed MoU on Healthcare
Astana, Kazakhstan • 09 February 2023

Kazakhstan and AstraZeneca Signed MoU on Healthcare

AstraZeneca considers the possibility of localizing production in the country

QazMonitor Logo
Michele Lapini/Getty Images
Michele Lapini/Getty Images

Kazakhstan’s ministry of healthcare and multinational biopharmaceutical company AstraZeneca signed a Memorandum of Understanding (MoU), QazMonitor reports.

AstraZeneca is a leading pharmaceutical company that has an extensive product portfolio for the treatment of a wide range of major diseases – oncological, cardiovascular, gastrointestinal, infectious, neurological, respiratory, and inflammatory.

In 2020, the company was involved in developing the Oxford-AstraZeneca COVID-19 vaccine.

gov.kz
gov.kz

The signing took place during the 9th Kazakh-British Intergovernmental Commission on Trade, Economic, Scientific, Technical, and Cultural Cooperation in London on February 7.

The parties discussed the possibility of localizing the production of AstraZeneca’s innovative drugs in Kazakhstan.

The first vice-minister of healthcare Timur Sultangaziyev noted that the document will contribute to the development of the pharmaceutical industry in Kazakhstan and increase the availability of innovative medicine to the general population.

In addition, the official hopes that it will also encourage local manufacturing enterprises to expand contract production.

The established partnership is expected to facilitate the development of effective international practices in the country's healthcare system and the exchange of experience between Kazakh and British medical workers.

Only 30% of an article published on The Qazaqstan Monitor website may be used with a mandatory hyperlink provided to indicate the original source. To re-publish the full article, written permission from the editorial is required.